- Home
- NCNA vs EKSO Comparison
NCNA vs EKSO Comparison
Compare NCNA & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCNA
- EKSO
- Stock Information
- Founded
- NCNA 1997
- EKSO 2005
- Country
- NCNA United Kingdom
- EKSO United States
- Employees
- NCNA N/A
- EKSO N/A
- Industry
- NCNA Biotechnology: Pharmaceutical Preparations
- EKSO Medical/Dental Instruments
- Sector
- NCNA Health Care
- EKSO Health Care
- Exchange
- NCNA Nasdaq
- EKSO Nasdaq
- Market Cap
- NCNA 7.6M
- EKSO 7.7M
- IPO Year
- NCNA 2017
- EKSO N/A
- Fundamental
- Price
- NCNA $3.82
- EKSO $4.32
- Analyst Decision
- NCNA
- EKSO Strong Buy
- Analyst Count
- NCNA 0
- EKSO 2
- Target Price
- NCNA N/A
- EKSO $7.75
- AVG Volume (30 Days)
- NCNA 76.4K
- EKSO 40.8K
- Earning Date
- NCNA 11-13-2025
- EKSO 10-28-2025
- Dividend Yield
- NCNA N/A
- EKSO N/A
- EPS Growth
- NCNA N/A
- EKSO N/A
- EPS
- NCNA N/A
- EKSO N/A
- Revenue
- NCNA N/A
- EKSO $14,749,000.00
- Revenue This Year
- NCNA N/A
- EKSO N/A
- Revenue Next Year
- NCNA N/A
- EKSO $49.96
- P/E Ratio
- NCNA N/A
- EKSO N/A
- Revenue Growth
- NCNA N/A
- EKSO N/A
- 52 Week Low
- NCNA $2.78
- EKSO $2.73
- 52 Week High
- NCNA $330.00
- EKSO $14.97
- Technical
- Relative Strength Index (RSI)
- NCNA 50.98
- EKSO 48.70
- Support Level
- NCNA $3.10
- EKSO $3.86
- Resistance Level
- NCNA $3.88
- EKSO $4.32
- Average True Range (ATR)
- NCNA 0.28
- EKSO 0.39
- MACD
- NCNA 0.07
- EKSO -0.04
- Stochastic Oscillator
- NCNA 81.19
- EKSO 41.64
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.